Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome.
Yuko YamagishiMotoi KuwaharaHidekazu SuzukiMasahiro SonooSatoshi KuwabaraTakanori YokotaKyoichi NomuraAtsuro ChibaRyuji KajiTakashi KandaKen-Ichi KaidaTatsuro MutohRyo YamasakiHiroshi TakashimaMakoto MatsuiKazutoshi NishiyamaSatomi MitsuhashiSusumu KusunokiPublished in: Journal of neurology, neurosurgery, and psychiatry (2020)
The combination of serum IgG anti-GD1a antibodies and a high mEGOS could help in making a more accurate prognosis of patients than mEGOS alone, especially for predicting poor outcomes.